Mr. Jean-Marc Leveille reports

KDA GROUP ANNOUNCES THE ACQUISITION OF THE MINORITY INTEREST IN ITS SUBSIDIARY GROUPE TECHNOLOGIQUE KDA INC.

KDA Group Inc. has closed the transaction pursuant to which the corporation acquired the 20-per-cent minority interest in the issued and outstanding shares of its subsidiary, Groupe Technologique KDA Inc. (GTK), held by ERxpert Inc., in exchange for 35 million common shares of KDA's share capital issued to ERxpert.

The corporation announced on Nov. 25, 2025, Dec. 24, 2025, and March 2, 2026, that it had entered into a share transfer agreement with ERxpert to complete the transaction and had obtained conditional approval from the TSX Venture Exchange on Dec. 18, 2025. The TSX Venture Exchange has approved the completion of the transaction, which was finalized today, March 24, 2026.

The corporation also announces the departure of GTK's former president, Yves Marmet, who has been replaced by Jean-Marc Leveille. Mr. Leveille is also a director of GTK. "On behalf of myself and GTK, we thank Yves for his work at GTK over the past few years, first as a consultant and then as president of GTK. We wish him all the best in his future endeavours," said Mr. Leveille.

About KDA Group Inc.

KDA Group is a leader in technological innovations and specialized software solutions (SaaS -- software as a service) for the health care professionals' market. KDA is a corporation that offers high-quality products and has recognized and respected expertise among the various stakeholders in the pharmaceutical and medical sectors. The technology products developed by KDA aim, among other things, to accelerate the health care's digital transformation, and are available for the Canadian and international markets.

We seek Safe Harbor.